Answer
Patients should be observed for infusion-related reactions for at least one hour after a Lamzede (velmanase alfa) infusion, according to clinical conditions and the physician's judgment.
Sources for this answer
- Lamzede 10 mg powder for solution for infusionChiesi Limited · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked